Skip to Main content Skip to Navigation
Journal articles

Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism

Josef Finsterer 1, * Sinda Zarrouk-Mahjoub 2 
* Corresponding author
1 Krankenanstalt Rudolfstiftung
2 LR11IPT05 - Laboratoire de Génomique Biomédicale et Oncogénétique - Biomedical Genomics and Oncogenetics Laboratory
Abstract : Correspondance
Keywords : FGF21 Genotype Lymphocytes Mitochondrial Phenotype mtDNA
Document type :
Journal articles
Complete list of metadata

Cited literature [2 references]  Display  Hide  Download
https://hal-riip.archives-ouvertes.fr/pasteur-02017153
Contributor : AbdelHakim Ben Hassine Connect in order to contact the contributor
Submitted on : Wednesday, February 13, 2019 - 9:06:02 AM
Last modification on : Wednesday, October 28, 2020 - 9:52:05 AM

File

Vignette du document
Fibroblast growth.pdf
Publication funded by an institution

Licence

Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives 4.0 International License

Identifiers

Collections

RIIP | RIIP_TUNIS

Citation

Josef Finsterer, Sinda Zarrouk-Mahjoub. Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism. Molecular Genetics and Metabolism Reports, Elsevier, 2018, 14, pp.1-2. ⟨10.1016/j.ymgmr.2017.10.005⟩. ⟨pasteur-02017153⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

13

Files downloads

44